42
Participants
Start Date
May 31, 2003
Primary Completion Date
March 31, 2004
Study Completion Date
December 31, 2006
RASi plus carvedilol
Patients were randomly assigned to 2 groups, with 1 group receiving renin-angiotensin system inhibitors (enalapril) plus carvedilol and the other receiving renin-angiotensin system inhibitors (enalapril) plus placebo
Chagas Disease Outpatient Center of the Federal University of Minas Gerais, Belo Horizonte
Federal University of Minas Gerais
OTHER